Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 168

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Association of Histologic Variants in FSGS Clinical Trial with Presenting Features and Outcomes

Open access
D’Agati, Vivette D., Alster, Joan M., Jennette, J. Charles, Thomas, David B., Pullman, James, Savino, Daniel A., Cohen, Arthur H., Gipson, Debbie S., Gassman, Jennifer J., Radeva, Milena K., Moxey-Mims, Marva M., Friedman, Aaron L., Kaskel, Frederick J., Trachtman, Howard, Alpers, Charles E., Fogo, Agnes B., Greene, Tom H., Nast, Cynthia C.·2013·Clinical Journal of the American Society of Nephrology

Abstract

Summary: Background and objectives: FSGS histologic variants have correlated with outcomes in retrospective studies. The FSGS Clinical Trial provided a unique opportunity to study the clinical impact of histologic variants in a well defined prospective cohort with steroid-resistant primary FSGS. Design, setting, participants, & measurements: Renal biopsies of 138 FSGS Clinical Trial participants aged 2–38 years enrolled from 2004 to 2008 were analyzed using the Columbia classification by core pathologists. This study assessed the distribution of histologic variants and examined their clinical and biopsy characteristics and relationships to patient outcomes. Results: The distribution of histologic variants was 68% (n=94) FSGS not otherwise specified, 12% (n=16) collapsing, 10% (n=14) tip, 7% (n=10) perihilar, and 3% (n=4) cellular. Individuals with not otherwise specified FSGS were more likely to have subnephrotic proteinuria (P=0.01); 33% of teenagers and adults had tip or collapsing variants compared with 10% of children, and subjects with these variants had greater proteinuria and hypoalbuminemia than not otherwise specified patients. Tip variant had the strongest association with white race (86%) and the lowest pathologic injury scores, baseline creatinine, and rate of progression. Collapsing variant had the strongest association with black race (63%, P=0.03) and the highest pathologic injury scores (P=0.003), baseline serum creatinine (P=0.003), and rate of progression. At 3 years, 47% of collapsing, 20% of not otherwise specified, and 7% of tip variant patients reached ESRD (P=0.005). Conclusions: This is the first prospective study with protocol-defined immunomodulating therapies confirming poor renal survival in collapsing variant and showing better renal survival in tip variant among steroid-resistant patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2215/cjn.06100612

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 168

Metadata

Authors
D’Agati, V. D., Alster, J. M., Jennette, J. C., Thomas, D. B., Pullman, J., Savino, D. A., Cohen, A. H., Gipson, D. S., Gassman, J. J., Radeva, M. K., Moxey-Mims, M. M., Friedman, A. L., Kaskel, F. J., Trachtman, H., Alpers, C. E., Fogo, A. B., Greene, T. H., & Nast, C. C.
Venue
Clinical Journal of the American Society of Nephrology
Published
2013-03
Volume
8
Issue
3
Pages
399-406
ISSN
1555-9041 (ISSN-L)
OpenAlex
W2170767337
Cited by
168
References
1
FWCI
7.00
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of Histologic Variants in FSGS Clinical Trial with Presenting Features and Outcomes. https://app.cochat.ai/papers/10.2215/cjn.06100612
The paper
D’Agati, V. D., Alster, J. M., Jennette, J. C., Thomas, D. B., Pullman, J., Savino, D. A., Cohen, A. H., Gipson, D. S., Gassman, J. J., Radeva, M. K., Moxey-Mims, M. M., Friedman, A. L., Kaskel, F. J., Trachtman, H., Alpers, C. E., Fogo, A. B., Greene, T. H., & Nast, C. C. (2013). Association of Histologic Variants in FSGS Clinical Trial with Presenting Features and Outcomes. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.06100612

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.